Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACH-CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-03-22 | 2024-03-23 | 223118 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-06-27 | 2019-11-01 | 87690 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92192 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-01-09 | 2020-06-25 | 102890 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-02-07 | 2020-06-11 | 105583 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120899 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2021-07-15 | 2021-09-02 | 142619 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-19 | 2023-06-09 | 181599 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183413 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-06-16 | 2023-07-28 | 195115 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |